首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).
【24h】

Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).

机译:血液透析中的钙平衡-不要过多地降低透析液中钙的浓度(部分)。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The debate on the most adequate dialysate calcium concentration for intermittent haemodialysis therapy is ongoing. There is probably no one optimal concentration. In general, one would like to maintain a neutral calcium balance in adult haemodialysis patients. However, a slightly negative balance may be preferable to avoid soft-tissue calcium accumulation in face of net calcium loss from the bone with ageing. The problem with measurements of calcium balance is that they are generally imprecise, as are estimations of total body calcium and its distribution in various compartments, unless done with labour-intensive methods and great care. The choice of the dialysate calcium will depend on several factors, including parathyroid and vitamin D status, type and severity of concomitant bone disease, presence or absence of arterial calcification, dietary habits, drug treatment and dialysis modality. Ideally the dialysate calcium would be adapted to each patient's needs. This is not feasible, however, in most dialysis settings and neither is it cost-effective. From a practical point of view, a relatively high dialysate calcium concentration in the range of of 1.50-1.75 mmol/L (3.0-3.5 mEq/L) should probably be preferred in haemodialysis patients with high serum PTH levels who are not prescribed calcium-based phosphate binders or high doses of active vitamin D sterols, and in those who are receiving a calcimimetic. In those who are treated with high doses of calcium-based binders and/or active vitamin D derivatives or who have a very low serum PTH level, the optimal dialysate calcium concentration is probably lower, in the range of 1.25-1.50 mmol/L (2.50-3.0 mEq/L). In the present pro/con debate about the optimal dialysate calcium concentration used for the haemodialysis session, we have accepted to defend the viewpoint that a low calcium concentration may do more harm than benefit in many patients. This viewpoint is opposite to that taken by Gotch. He argues that since calcitriol and other active vitamin D derivatives have become available virtually all haemodialysis patients are in positive calcium balance. We would like to take issue with this statement and warn against the indiscriminate use of a low calcium dialysate in all patients receiving haemodialysis therapy.
机译:关于用于间歇性血液透析治疗的最适当的透析液钙浓度的争论仍在进行中。可能没有一个最佳浓度。通常,成人血液透析患者希望维持中性的钙平衡。但是,略微负的平衡可能是优选的,以避免随着年龄的增长而从骨骼中净吸收钙,从而导致软组织钙的积累。钙平衡测量的问题是,它们通常是不精确的,除非对身体中的钙及其在各个隔室中的分布进行估算,否则除非进行劳动强度大的方法和精心照料。透析液钙的选择将取决于几个因素,包括甲状旁腺和维生素D的状态,伴随骨疾病的类型和严重性,是否存在动脉钙化,饮食习惯,药物治疗和透析方式。理想地,透析液钙将适合每个患者的需求。但是,这在大多数透析环境中都是不可行的,而且也不具有成本效益。从实用的角度来看,对于血清PTH水平较高但未开钙的血液透析患者,透析液钙浓度在1.50-1.75 mmol / L(3.0-3.5 mEq / L)的范围内可能更可取。磷酸盐粘合剂或高剂量的活性维生素D固醇,以及正在接受拟钙剂的患者。在接受大剂量钙基粘合剂和/或活性维生素D衍生物治疗或血清PTH水平非常低的患者中,最佳透析液钙浓度可能较低,范围为1.25-1.50 mmol / L( 2.50-3.0 mEq / L)。在当前关于血液透析中使用的最佳透析液钙浓度的争论中,我们接受了捍卫这样的观点,即低钙浓度对许多患者造成的危害大于益处。这种观点与Gotch的观点相反。他认为,自从骨化三醇和其他活性维生素D衍生物问世以来,几乎所有血液透析患者的钙平衡都处于正值。我们希望对此声明表示怀疑,并警告不要在接受血液透析治疗的所有患者中随意使用低钙透析液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号